Suchergebnisse - "Carlo-Stella, Carmelo"

PubPharm (22)

1

Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma : A phase 1/2 study

enthalten in: Cancer medicine | 2023

von Lesokhin, A. | LeBlanc, R. | Dimopoulos, M. | +18

2

BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas

enthalten in: Nature communications | 2023

von Moreno, V. | Vieito, M. | Sepulveda, J. | +18

3

Copanlisib for the treatment of adults with relapsed follicular lymphoma

enthalten in: Expert review of clinical pharmacology | 2020

von Magagnoli, M. | Carlo-Stella, C. | Santoro, A.

4

A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Kahl, B. | Hamadani, M. | Radford, J. | +12

5

Vascular amounts and dispersion of caliber-classified vessels as key parameters to quantitate 3D micro-angioarchitectures in multiple myeloma experimental tumors

enthalten in: Scientific reports | 2018

von Righi, M. | Locatelli, S. | Carlo-Stella, C. | +2

6

Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma

enthalten in: Blood | 2018

von Spina, V. | Bruscaggin, A. | Cuccaro, A. | +34

CommentIn: Blood. 2018 May 31;131(22):2407-2408. - PMID 29853457

7

Italian real-life experience with brentuximab vedotin : results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma

enthalten in: Haematologica | 2017

von Broccoli, A. | Pellegrini, C. | Di Rocco, A. | +39

8

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis

enthalten in: Nature communications | 2017

von Trabanelli, S. | Chevalier, M. | Martinez-Usatorre, A. | +39

9

Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma

enthalten in: Blood | 2017

von Merryman, R. | Kim, H. | Zinzani, P. | +28

10

Primary refractory and early-relapsed Hodgkin's lymphoma : strategies for therapeutic targeting based on the tumour microenvironment

enthalten in: The Journal of pathology | 2015

von Carbone, A. | Gloghini, A. | Castagna, L. | +2